WIPI-2 inhibitors belong to a class of chemical compounds that have gained prominence in the field of cellular biology and autophagy research. WIPI-2, which stands for WD-repeat protein interacting with phosphoinositides 2, is a protein that plays a pivotal role in the autophagy pathway, a fundamental cellular process responsible for degrading and recycling cellular components and organelles. Autophagy is crucial for maintaining cellular homeostasis and responding to various cellular stresses, including nutrient deprivation, infection, and protein aggregation. WIPI-2 is one of the several factors that participate in the early stages of autophagosome formation, a critical step in the autophagy process.
WIPI-2 inhibitors are designed to target and modulate the activity of WIPI-2, interfering with its role in autophagosome formation and autophagic processes. This interference can lead to alterations in the autophagy pathway, affecting the cell's ability to initiate autophagosome formation and efficiently degrade cellular components. Researchers employ WIPI-2 inhibitors as valuable tools to investigate the specific functions and regulatory mechanisms of WIPI-2 in different cellular contexts and to gain insights into the molecular underpinnings of autophagy, a process intimately linked to various aspects of cellular physiology and pathology. While the precise applications and broader implications of WIPI-2 inhibitors are subjects of ongoing research, their utility in elucidating the intricacies of autophagic regulation and its impact on cellular health is of paramount importance in advancing our understanding of molecular and cell biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
An inhibitor of phosphoinositide 3-kinases, which may lead to decreased autophagic activity and could lower WIPI-2 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor that could disrupt the PI3K/Akt/mTOR pathway and potentially downregulate WIPI-2 expression. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Promotes the degradation of PI3K, which could indirectly lead to decreased levels of WIPI-2. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Known to inhibit autophagy by preventing autophagosome-lysosome fusion, possibly reducing the cellular need for WIPI-2. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $56.00 | 1 | |
Similar to chloroquine, it inhibits autophagy, which could theoretically suppress WIPI-2 expression. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
A VPS34 inhibitor that can impede autophagy, potentially lowering WIPI-2 expression as part of the feedback mechanism. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially affecting the expression of autophagy-related proteins, including WIPI-2. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Specifically inhibits V-ATPase, which can lead to autophagy inhibition and might impact WIPI-2 expression. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
An mTOR inhibitor that promotes autophagy but may alter the expression of autophagy-related genes including WIPI-2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Another mTOR inhibitor that could have complex effects on the expression of autophagy-related proteins. | ||||||